進階篩選

Technical category
技術研發單位
    • 5D智慧城市─SmartES平台

      AI & IOT Application FutureTech 5D智慧城市─SmartES平台

      NCREE has originally developed 5D digital space—on the basis of 3D city modelsconnections of different kinds of sensors around the world— is an online to offline virtual space with a combination of rising 5G technology advantages. Collectingreorganizing various 3D cartographic data with Building Information Modeling (BIM), satellite imagery, UAV 3D modeling, LiDar point cloud data, etc., can increase the diversity of the buildinglandscape. 5D+5G smart city platform would accelerate the 5D smart city to become the digital twin of a real city.
    • 突破物聯網的最後一哩:無晶片射頻辨識

      Electronic & Optoelectronics FutureTech 突破物聯網的最後一哩:無晶片射頻辨識

      The major cost of conventional RFID tags comes from a microchip. To reduce the start-up cost, we develop a chipless RFID system that eliminates the use of the chip. This research organize the real-world issues of chipless RFID into four subjects, including the design of chipless tags, chipless RFID readers, reader signal processing,wireless propagation channel. We successfully integrate the four topics, developing a calibration-free, orientation-insensitive,high-capacity chipless RFID system with multi-tag detection capability.
    • 治療多種癌症與纖維化之首創抗體新藥

      FutureTech 治療多種癌症與纖維化之首創抗體新藥

      Ninety percent of human diseases are related to abnormal inflammation. WJM team has successfully developed a new monoclonal antibody that can inhibit a key inflammation protein. Animal experiments have accumulated more than ten disease modes, including a variety of solid tumors, fibrosis, degenerativecardiovascular diseases. This antibody is qualified as an orphan drug for the treatment of IPF. New coronary pneumonia has greatly increased the demand for pulmonary fibrosis treatment,has also become an important target for mergersacquisitions of global pharmaceutical companies.
    • 全方位血液細胞影像與生化分析系統

      FutureTech 全方位血液細胞影像與生化分析系統

      Our system is achieved by integrating diffractiondeep learning methods, which allows high-throughput lensless imaging system to display wide rangehigh-resolution images. In addition, the developed extraction chipsprototype were verified to accurately detect the numberproportion of blood cells under low blood demand. Our system shows great potential in point-of-care blood cells monitoring for cancer patients that could reduce infection riskmortality rate, increase efficacy of chemotherapysupport precision medicine.
    • A genomic marker guided roadmap to treat hepatocellular carcinoma

      Bio-tech & New Drugs FutureTech A genomic marker guided roadmap to treat hepatocellular carcinoma

      This is a method for identifying single nucleotide polymorphisms (GALNT14 genotypes) of a target nucleic acid for predicting whether a patient suffering from HCC will respond to combination chemotherapy. Accordingly, physicians can decide whether the HCC patients should receive chemotherapyTACE. This method could also predict prognosis in multiple gastrointestinal cancers.